Kornitzer Capital Management Inc Adma Biologics, Inc. Transaction History
Kornitzer Capital Management Inc
- $4.91 Billion
- Q4 2024
A detailed history of Kornitzer Capital Management Inc transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Kornitzer Capital Management Inc holds 33,000 shares of ADMA stock, worth $559,350. This represents 0.01% of its overall portfolio holdings.
Number of Shares
33,000Holding current value
$559,350% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding ADMA
# of Institutions
323Shares Held
190MCall Options Held
917KPut Options Held
91.6K-
Black Rock Inc. New York, NY18.6MShares$316 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.1MShares$307 Million0.01% of portfolio
-
State Street Corp Boston, MA13MShares$220 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA12.6MShares$214 Million0.05% of portfolio
-
Morgan Stanley New York, NY8.6MShares$146 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.33B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...